T cells, including CD8+ cytotoxic T lymphocytes (CTLs), regulatory CD4+ (Treg), and conventional CD4+ T cells, constitute 1–5% of the total glioma cellular content [110,111]. This evidence concerns the gene CD8A and central nervous system cancer.